Pancreatic Tumor Markers

  • John R. Hobbs
Part of the Contemporary Biomedicine book series (CB, volume 2)


Adenocarcinoma of the pancreas has shown a real increase in recent years, accounting for 4.5% of all deaths certified as owing to malignancy, and has always created serious problems for clinicians, because current 5–10 year survivals following attempts at curative therapy are abysmally low at 1–5% (Silverberg, 1977). Careful postmortem examination in a Norwegian series showed that, although 3% of the deaths certified as resulting from cancer were correctly indicated to be of pancreatic origin, a further 2% needed to be added after postmortem examination, producing a true figure of 5% from autopsy studies (Hartveit, 1979). Cancer of the pancreas is thus now among the fourth or fifth commonest of killing cancers. This increase is probably the result of smoking (Krain, 1970).


Pancreatic Cancer Acute Pancreatitis Chronic Pancreatitis Pancreatic Juice Obstructive Jaundice 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Arndt, R., K. Nishida, W.-M. Becker, and H.-G. Thiele (1978), Proceedings of the 6th Meeting of the International Society for Oncodevelopmental Biology and Medicine Abstract 229.Google Scholar
  2. Banwo, O., J. Versey, and J. R. Hobbs (1974), Lancet 1, 643.PubMedCrossRefGoogle Scholar
  3. Concannon, J., M. H. Dalbow, S. E. Hodgson, J. J. Headings, E. Markopoulos, J. Mitchell, W. J. Cushing, and G. A. Liebler (1978), Cancer 42, (3 Suppl.), 1477.PubMedCrossRefGoogle Scholar
  4. DiMagno, E. P., J.-R. Malagelada, C. G. Moertel, and V. L. W. Go (1977), Gastroenterology 73, 457.PubMedGoogle Scholar
  5. FDA Drug Bulletin (January, 1974).Google Scholar
  6. Fedail, S. S., R. Harvey, P. R. Salmon, and A. E. Read (1978), Brit. Med. J. 1, 304.PubMedCrossRefGoogle Scholar
  7. Gelder, F. B., C. J. Reese, A. R. Moossa, T. Hall, and R. Hunter (1978), Cancer Res. 38, 313.PubMedGoogle Scholar
  8. Goldenberg, D. M., F. DeLand, E. Kim, S. Bennett, F. J. Primus, J. R. van Nagell, N. Estes, P. DeSimone, and P. Rayburn (1978), New Eng. J. Med. 298, 1384.PubMedCrossRefGoogle Scholar
  9. Hartveit, F. (1979), J. Pathol. 129, 111.PubMedCrossRefGoogle Scholar
  10. Hegelund, H., N. H. Axelsen, E. Bock, B. Nørgaard-Pedersen, and O. C. Røder (1976), Protides of the Biological Fluids 24, 525.Google Scholar
  11. Hobbs, J. R. (1974), Lancet 2, 1305.PubMedCrossRefGoogle Scholar
  12. Hobbs, J. R., O. Banwo, and J. M. B. Versey (1976), Die Untersuchung der Bauchspeicheldrüse 45.Google Scholar
  13. Hobbs, J. R., D. J. Evans, and O. M. Wrong (1974), Brit. Med. J. 2, 87.PubMedCrossRefGoogle Scholar
  14. Hobbs, J. R., M. L. Knapp, and A. C. Branfoot (1980), Oncofetal Biol. Med. 1, 37.Google Scholar
  15. Knapp, M. L., and J. R. Hobbs (1980), Protides of the Biological Fluids 21, 63.Google Scholar
  16. Krain, L. S. (1970), J. Surg. Oncol. 2, 115.PubMedCrossRefGoogle Scholar
  17. Lindstedt, G., P.-A. Lundberg, and P. Rolny (1979), Cancer 43, 2465.PubMedCrossRefGoogle Scholar
  18. Mihas, A. A. (1978), J. Natl. Cancer Inst. 60, 1439.PubMedGoogle Scholar
  19. Nishida, K., M. Sugiura, T. Yoshikawa, and M. Kondo (1980), Lancet 1, 262.PubMedCrossRefGoogle Scholar
  20. Oon, C.-J., M. Apsey, H. Buckleton, K. B. Cooke, I. Hanham, A. Hazarika, J. R. Hobbs, and B. McLeod (1975), Behring Inst. Mitt. 56, 228.Google Scholar
  21. Silverberg, E. (1977), Ca-A Cancer J. Clin. 27, 26.CrossRefGoogle Scholar
  22. Wood, R. A. B., and A. R. Moossa (1977), Brit. J. Surg. 64, 718.PubMedCrossRefGoogle Scholar
  23. Zamcheck, N., (1976), Clinics Gastroenterol. 5, 625.Google Scholar

Copyright information

© HUMANA Press Inc. 1982

Authors and Affiliations

  • John R. Hobbs
    • 1
  1. 1.Department of Chemical PathologyWestminster Medical SchoolLondonGreat Britain

Personalised recommendations